世界の水疱性類天疱瘡治療市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV11210)
◆英語タイトル:Global Bullous Pemphigoid Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV11210
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:91
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは水疱性類天疱瘡治療の世界市場について調査・分析した資料です。種類別(免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬)の市場規模、用途別(病院薬局、小売薬局、通信販売薬局)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別水疱性類天疱瘡治療の競争状況、市場シェア
・世界の水疱性類天疱瘡治療市場:種類別市場規模 2015年-2020年(免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬)
・世界の水疱性類天疱瘡治療市場:種類別市場規模予測 2021年-2026年(免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬)
・世界の水疱性類天疱瘡治療市場:用途別市場規模 2015年-2020年(病院薬局、小売薬局、通信販売薬局)
・世界の水疱性類天疱瘡治療市場:用途別市場規模予測 2021年-2026年(病院薬局、小売薬局、通信販売薬局)
・北米の水疱性類天疱瘡治療市場分析:米国、カナダ
・ヨーロッパの水疱性類天疱瘡治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの水疱性類天疱瘡治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の水疱性類天疱瘡治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの水疱性類天疱瘡治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Pfizer、Aqua Pharmaceuticals、Sirius Laboratories、DUBLIN Pharmaceuticals、Teva Pharmaceuticals、Astellas Pharma、Aegis Pharmaceuticals、Sun Pharmaceuticals
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Bullous pemphigoid is a chronic, inflammatory skin disease that involves the formation of blisters. The bullous may be of different forms such as generalized, vesicular, vegetative, Urticarial, Nodular, Acral or infant forms. The disease is not gender biased and can also occur in younger adults but is rare in infants. The blood blister due to bullous pemphigoid occur in people aging above 70 years.  Bullous pemphigoid occurs when the immune system outbreaks a thin layer of tissue below the outer layer of skin. It is more prevalent in patients suffering from dermatitis and neurological disease, predominantly in stroke and dementia. The bullous pemphigoid blister develops on the skin area that tend to flex such as lower abdomen, upper thigh and armpits. Bullous Pemphigoid causes severe itch, tense bullae, annular lesions, post inflammatory pigmentation, blood stained blister fluids and urticaria-like red skin. Proper medication involved in overturning the immune system plays an important role in treatment of the disease.
Rising geriatric population over the globe increase chances of occurrence of disease and thus the surge in treatment options. Common and non-expensive medication uses in the treatment of disease increases fuels the treatment market. Furthermore, various awareness programs by healthcare organizations and NGOs supports the proliferation of treatment market. Non-availability of healthcare facilities in various less developed regions of globe with high incidence rate of disease restricts the overall market to grow.

Market Analysis and Insights: Global Bullous Pemphigoid Treatment Market
The global Bullous Pemphigoid Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Bullous Pemphigoid Treatment Scope and Market Size
Bullous Pemphigoid Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bullous Pemphigoid Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Aqua Pharmaceuticals
Sirius Laboratories
DUBLIN Pharmaceuticals
Teva Pharmaceuticals
Astellas Pharma
Aegis Pharmaceuticals
Sun Pharmaceuticals

Market segment by Type, the product can be split into
Immunosuppressant Medication
Steroids
Antibiotics & Antiseptics
Pain Relief Medication
Market segment by Application, split into
Hospitals Pharmacies
Retail Pharmacies
Mail Order Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bullous Pemphigoid Treatment Revenue
1.4 Market by Type
1.4.1 Global Bullous Pemphigoid Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunosuppressant Medication
1.4.3 Steroids
1.4.4 Antibiotics & Antiseptics
1.4.5 Pain Relief Medication
1.5 Market by Application
1.5.1 Global Bullous Pemphigoid Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Mail Order Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Bullous Pemphigoid Treatment Market Perspective (2015-2026)
2.2 Global Bullous Pemphigoid Treatment Growth Trends by Regions
2.2.1 Bullous Pemphigoid Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bullous Pemphigoid Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Bullous Pemphigoid Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bullous Pemphigoid Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Bullous Pemphigoid Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Bullous Pemphigoid Treatment Players by Market Size
3.1.1 Global Top Bullous Pemphigoid Treatment Players by Revenue (2015-2020)
3.1.2 Global Bullous Pemphigoid Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Bullous Pemphigoid Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bullous Pemphigoid Treatment Market Concentration Ratio
3.2.1 Global Bullous Pemphigoid Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bullous Pemphigoid Treatment Revenue in 2019
3.3 Bullous Pemphigoid Treatment Key Players Head office and Area Served
3.4 Key Players Bullous Pemphigoid Treatment Product Solution and Service
3.5 Date of Enter into Bullous Pemphigoid Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Bullous Pemphigoid Treatment Historic Market Size by Type (2015-2020)
4.2 Global Bullous Pemphigoid Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Bullous Pemphigoid Treatment Market Size by Application (2015-2020)
5.2 Global Bullous Pemphigoid Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Bullous Pemphigoid Treatment Market Size (2015-2020)
6.2 Bullous Pemphigoid Treatment Key Players in North America (2019-2020)
6.3 North America Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
6.4 North America Bullous Pemphigoid Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Bullous Pemphigoid Treatment Market Size (2015-2020)
7.2 Bullous Pemphigoid Treatment Key Players in Europe (2019-2020)
7.3 Europe Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
7.4 Europe Bullous Pemphigoid Treatment Market Size by Application (2015-2020)

8 China
8.1 China Bullous Pemphigoid Treatment Market Size (2015-2020)
8.2 Bullous Pemphigoid Treatment Key Players in China (2019-2020)
8.3 China Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
8.4 China Bullous Pemphigoid Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Bullous Pemphigoid Treatment Market Size (2015-2020)
9.2 Bullous Pemphigoid Treatment Key Players in Japan (2019-2020)
9.3 Japan Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
9.4 Japan Bullous Pemphigoid Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Bullous Pemphigoid Treatment Market Size (2015-2020)
10.2 Bullous Pemphigoid Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Bullous Pemphigoid Treatment Market Size by Application (2015-2020)

11 India
11.1 India Bullous Pemphigoid Treatment Market Size (2015-2020)
11.2 Bullous Pemphigoid Treatment Key Players in India (2019-2020)
11.3 India Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
11.4 India Bullous Pemphigoid Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Bullous Pemphigoid Treatment Market Size (2015-2020)
12.2 Bullous Pemphigoid Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
12.4 Central & South America Bullous Pemphigoid Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Bullous Pemphigoid Treatment Introduction
13.1.4 Pfizer Revenue in Bullous Pemphigoid Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Aqua Pharmaceuticals
13.2.1 Aqua Pharmaceuticals Company Details
13.2.2 Aqua Pharmaceuticals Business Overview
13.2.3 Aqua Pharmaceuticals Bullous Pemphigoid Treatment Introduction
13.2.4 Aqua Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.2.5 Aqua Pharmaceuticals Recent Development
13.3 Sirius Laboratories
13.3.1 Sirius Laboratories Company Details
13.3.2 Sirius Laboratories Business Overview
13.3.3 Sirius Laboratories Bullous Pemphigoid Treatment Introduction
13.3.4 Sirius Laboratories Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.3.5 Sirius Laboratories Recent Development
13.4 DUBLIN Pharmaceuticals
13.4.1 DUBLIN Pharmaceuticals Company Details
13.4.2 DUBLIN Pharmaceuticals Business Overview
13.4.3 DUBLIN Pharmaceuticals Bullous Pemphigoid Treatment Introduction
13.4.4 DUBLIN Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.4.5 DUBLIN Pharmaceuticals Recent Development
13.5 Teva Pharmaceuticals
13.5.1 Teva Pharmaceuticals Company Details
13.5.2 Teva Pharmaceuticals Business Overview
13.5.3 Teva Pharmaceuticals Bullous Pemphigoid Treatment Introduction
13.5.4 Teva Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.5.5 Teva Pharmaceuticals Recent Development
13.6 Astellas Pharma
13.6.1 Astellas Pharma Company Details
13.6.2 Astellas Pharma Business Overview
13.6.3 Astellas Pharma Bullous Pemphigoid Treatment Introduction
13.6.4 Astellas Pharma Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.6.5 Astellas Pharma Recent Development
13.7 Aegis Pharmaceuticals
13.7.1 Aegis Pharmaceuticals Company Details
13.7.2 Aegis Pharmaceuticals Business Overview
13.7.3 Aegis Pharmaceuticals Bullous Pemphigoid Treatment Introduction
13.7.4 Aegis Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.7.5 Aegis Pharmaceuticals Recent Development
13.8 Sun Pharmaceuticals
13.8.1 Sun Pharmaceuticals Company Details
13.8.2 Sun Pharmaceuticals Business Overview
13.8.3 Sun Pharmaceuticals Bullous Pemphigoid Treatment Introduction
13.8.4 Sun Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.8.5 Sun Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Pfizer、Aqua Pharmaceuticals、Sirius Laboratories、DUBLIN Pharmaceuticals、Teva Pharmaceuticals、Astellas Pharma、Aegis Pharmaceuticals、Sun Pharmaceuticals

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の水疱性類天疱瘡治療市場2026:インサイト・予測(Global Bullous Pemphigoid Treatment Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。